Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Koopman

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Plos One|March 26, 2015
Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control studyWillize E van der Starre, Cees van Nieuwkoop, Uginia Thomson, et al.
The Lancet. Infectious Diseases|October 6, 2023
Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trialLisanne A Overduin, Jan Pieter R Koopman, Corine Prins, et al.
Parasitology|November 5, 2021
Excretion patterns of <i>Schistosoma mansoni</i> antigens CCA and CAA by adult male and female worms, using a mouse model and <i>ex vivo</i> parasite culturesMiriam Casacuberta-Partal, Lisette van Lieshout, Angela van Diepen, et al.
Scientific Reports|March 2, 2022
Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, IndonesiaAldian I Amaruddin, Jan Pieter R Koopman, Munawir Muhammad, et al.
Science Immunology|July 5, 2024
Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infectionEmma L Houlder, Koen A Stam, Jan Pieter R Koopman, et al.
The Lancet. Microbe|December 2, 2023
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trialMarie-Astrid Hoogerwerf, Jacqueline J Janse, Vincent P Kuiper, et al.
Immunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human <i>Schistosoma mansoni</i> infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
Nature Communications|April 3, 2023
Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasisE L Houlder, A H Costain, I Nambuya, et al.
The Journal of Infectious Diseases|July 10, 2020
A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm InfectionMarie-Astrid Hoogerwerf, Jan Pieter R Koopman, Jacqueline J Janse, et al.
The Journal of Clinical Investigation|December 12, 2024
Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infectionJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Plos One|March 26, 2015
Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control studyWillize E van der Starre, Cees van Nieuwkoop, Uginia Thomson, et al.
The Lancet. Infectious Diseases|October 6, 2023
Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trialLisanne A Overduin, Jan Pieter R Koopman, Corine Prins, et al.
Parasitology|November 5, 2021
Excretion patterns of <i>Schistosoma mansoni</i> antigens CCA and CAA by adult male and female worms, using a mouse model and <i>ex vivo</i> parasite culturesMiriam Casacuberta-Partal, Lisette van Lieshout, Angela van Diepen, et al.
Scientific Reports|March 2, 2022
Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, IndonesiaAldian I Amaruddin, Jan Pieter R Koopman, Munawir Muhammad, et al.
Science Immunology|July 5, 2024
Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infectionEmma L Houlder, Koen A Stam, Jan Pieter R Koopman, et al.
The Lancet. Microbe|December 2, 2023
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trialMarie-Astrid Hoogerwerf, Jacqueline J Janse, Vincent P Kuiper, et al.
Immunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human <i>Schistosoma mansoni</i> infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
Nature Communications|April 3, 2023
Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasisE L Houlder, A H Costain, I Nambuya, et al.
The Journal of Infectious Diseases|July 10, 2020
A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm InfectionMarie-Astrid Hoogerwerf, Jan Pieter R Koopman, Jacqueline J Janse, et al.
The Journal of Clinical Investigation|December 12, 2024
Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infectionJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Pageof 7